SCHEMBL18274748

SCHEMBL18274748

CC(C)(C)c1cc(-c2ccccc2)c(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NC5CCN(C6CCOCC6)CC5)c([N+](=O)[O-])c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)cc1Cl

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 5/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957062 0.89 BCL2 (0.75) BCL2
SCHEMBL1955256 0.87 BCL2 (0.74) BCL2
SCHEMBL18274760 0.84 BCL2 (0.67) BCL2
SCHEMBL19424785 0.83 BCL2 (0.66) BCL2
SCHEMBL2828541 0.82 BCL2 (0.83) BCL2
SCHEMBL30467932 0.82 BCL2 (1.00) BCL2
SCHEMBL1807790 0.82 BCL2 (1.00) BCL2
SCHEMBL19419660 0.81 BCL2 (0.72) BCL2
SCHEMBL19424906 0.81 BCL2 (0.65) BCL2
SCHEMBL30314030 0.80 BCL2 (0.62) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP disclosed
Send feedback